Document is current
Any future updates will be listed below
-
Authors
Lee, Jii Bum
Yang, Junwon
Chalita, Mauricio
Jung, Yeonjae
Park, Haangik
Ro, Myungja
Kim, Hyun
Yang, Eunchong
Choi, Soeun
Kim, Minyoung
Min, Arim
Kwon, Bo-Eun
Im, Jieun
Kim, Hyunjeong
Park, Hyunkyung
Lim, Sun Min
Hong, Min Hee
Park, Sein
Kim, Yeong Ouk
Chun, Jongsik
Oh, Hyun-Seok https://orcid.org/0000-0001-8560-7132
Cho, Byoung Chul https://orcid.org/0000-0002-5562-270X
-
Funding
Funding for this research was provided by:
CJ Bioscience, Inc.
National Research Foundation of Korea (RS-2025-00557272)
Ministry of Food and Drug Safety (RS-2025-02215737)
- License Information
-
More Information
Article History
Received: 4 October 2025
Accepted: 16 July 2026
First Online: 6 August 2026
Declarations
Ethics approval and consent to participate: All participants provided written informed consent, and the protocol was approved by the Institutional Review Board of Yonsei Cancer Center (IRB 4–2022-0355). The study was conducted in accordance with the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: JY, MC, YJ, HK, EY, SC, MK, AM, BEK, JI, HJK, HKP, SP, YOK, JC, and HSO are employees of CJ Bioscience, Inc. The remaining authors declare no competing interests.
